de Bont JM - Search Results

1

Identification of apolipoprotein A-II in cerebrospinal fluid of pediatric brain tumor patients by protein expression profiling.

de Bont JM, den Boer ML, Reddingius RE, Jansen J, Passier M, van Schaik RH, Kros JM, Sillevis Smitt PA, Luider TH, Pieters R. de Bont JM, et al. Clin Chem. 2006 Aug;52(8):1501-9. doi: 10.1373/clinchem.2006.069294. Epub 2006 Jun 8. Clin Chem. 2006. PMID: 16762995

2

Management of hyperuricemia with rasburicase review.

de Bont JM, Pieters R. de Bont JM, et al. Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1431-40. doi: 10.1081/NCN-200027656. Nucleosides Nucleotides Nucleic Acids. 2004. PMID: 15571272 Review.

3

[Adolescents with acute lymphatic leukaemia achieve significantly better results when treated following Dutch paediatric oncology protocols than with adult protocols].

de Bont JM, van der Holt B, Dekker AW, van der Does-van den Berg A, Sonneveld P, Pieters R. de Bont JM, et al. Ned Tijdschr Geneeskd. 2005 Feb 19;149(8):400-6. Ned Tijdschr Geneeskd. 2005. PMID: 15751319 Dutch.

4

Identification of novel biomarkers in pediatric primitive neuroectodermal tumors and ependymomas by proteome-wide analysis.

de Bont JM, den Boer ML, Kros JM, Passier MM, Reddingius RE, Smitt PA, Luider TM, Pieters R. de Bont JM, et al. J Neuropathol Exp Neurol. 2007 Jun;66(6):505-16. doi: 10.1097/01.jnen.0000240475.35414.c3. J Neuropathol Exp Neurol. 2007. PMID: 17549010

5

Increased total-Tau levels in cerebrospinal fluid of pediatric hydrocephalus and brain tumor patients.

de Bont JM, Vanderstichele H, Reddingius RE, Pieters R, van Gool SW. de Bont JM, et al. Eur J Paediatr Neurol. 2008 Jul;12(4):334-41. doi: 10.1016/j.ejpn.2007.09.007. Epub 2007 Oct 22. Eur J Paediatr Neurol. 2008. PMID: 17951083

6

Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.

de Bont JM, van Doorn J, Reddingius RE, Graat GH, Passier MM, den Boer ML, Pieters R. de Bont JM, et al. Int J Cancer. 2008 Aug 1;123(3):594-600. doi: 10.1002/ijc.23558. Int J Cancer. 2008. PMID: 18478565

7

Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis.

de Bont JM, Kros JM, Passier MM, Reddingius RE, Sillevis Smitt PA, Luider TM, den Boer ML, Pieters R. de Bont JM, et al. Neuro Oncol. 2008 Oct;10(5):648-60. doi: 10.1215/15228517-2008-032. Epub 2008 Jun 24. Neuro Oncol. 2008. PMID: 18577562 Free PMC article.

8

Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

de Bont JM, Packer RJ, Michiels EM, den Boer ML, Pieters R. de Bont JM, et al. Neuro Oncol. 2008 Dec;10(6):1040-60. doi: 10.1215/15228517-2008-059. Epub 2008 Aug 1. Neuro Oncol. 2008. PMID: 18676356 Free PMC article. Review.

9

Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands.

de Bont JM, Holt Bv, Dekker AW, van der Does-van den Berg A, Sonneveld P, Pieters R. de Bont JM, et al. Leukemia. 2004 Dec;18(12):2032-5. doi: 10.1038/sj.leu.2403538. Leukemia. 2004. PMID: 15483674 No abstract available.

10

CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.

van Zutven LJ, van Drunen E, de Bont JM, Wattel MM, Den Boer ML, Pieters R, Hagemeijer A, Slater RM, Beverloo HB. van Zutven LJ, et al. Among authors: de bont jm. Leukemia. 2005 Jul;19(7):1281-4. doi: 10.1038/sj.leu.2403769. Leukemia. 2005. PMID: 15843818 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters